A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Autoinjector Atropine-Pralidoxime, Calcium Chloride, Calcium Gluconate9

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1000 mg	PO	not captured	standing	pages 153, 258
Other	peds	15 mg/kg	PO	not captured	standing	pages 153, 258
Mild to moderate pain	adult	1000 mg	PO	not captured	standing	pages 25, 258
Mild to moderate pain	adult	15 mg/kg	PO	not captured	standing	pages 25, 153
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	pages 25, 258

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	6 mg	IV/IO	not captured	standing	pages 94, 259
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 239, 259
Narrow-complex tachycardia	adult	6 mg	IV/IO	not captured	standing	pages 94, 259
Narrow-complex tachycardia	peds	0.1 mg/kg (max 6 mg)	IV/IO	not captured	standing	pages 94, 259

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	10 mg	NEB	not captured	standing	pages 50, 260
Other	peds	5 mg	NEB	not captured	standing	page 260
Respiratory distress	adult	5 mg	NEB	not captured	standing	pages 44, 48, 71, 260
Respiratory distress	peds	2.5 mg	NEB	not captured	standing	pages 44, 48, 71, 260

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	300 mg	IV/IO	not captured	standing	pages 83, 262
Cardiac arrest	peds	5 mg/kg	IV/IO	not captured	standing	pages 83, 262
Other	peds	5 mg/kg	IV	not captured	standing	pages 224, 262
Narrow-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 96, 262
Narrow-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 96, 262

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	325 mg	PO	not captured	standing	pages 85, 263

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 74, 209, 264, 265
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 74, 209, 264, 265
Nerve agent exposure	adult	2 mg	IV/IM	not captured	standing	pages 151, 220, 221, 264, 265
Nerve agent exposure	peds	0.05 mg/kg	IV/IM	not captured	standing	pages 151, 220, 221, 264, 265
Organophosphate poisoning	adult	2 mg	IV/IM	not captured	standing	pages 151, 220, 221, 264, 265
Organophosphate poisoning	peds	0.05 mg/kg	IV/IM	not captured	standing	pages 151, 220, 221, 264, 265
Other	adult	2 mg	IV/IM	not captured	standing	pages 151, 264
Other	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 209, 265
Other	peds	0.25 mg	IM	not captured	standing	pages 220, 221, 265
Other	peds	0.5 mg	IM	not captured	standing	pages 220, 221, 265
Other	peds	1 mg	IM	not captured	standing	pages 220, 221, 265
Other	peds	2 mg	IM	not captured	standing	pages 220, 221, 265

Autoinjector Atropine-Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	peds	0.5 mg/kg	IM	not captured	standing	pages 220, 221
Organophosphate poisoning	peds	0.25 mg/kg	IM	not captured	standing	pages 220, 221
Organophosphate poisoning	peds	1 mg	IM	not captured	standing	pages 220, 221

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 50, 81, 133, 177, 266
Other	adult	1 g	IV/IO	not captured	standing	pages 50, 266

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	3 g	IV/IO	not captured	standing	pages 50, 133, 177, 267
Other	adult	3 g	IV/IO	not captured	standing	pages 50, 267

D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl9

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	10 mg	IV/IO	not captured	standing	pages 44, 48
Other	adult	10 mg	IV/IO	not captured	standing	pages 44, 48
Other	adult	10 mg	PO	not captured	standing	page 48
Other	adult	8 mg	IV/IM/PO	not captured	standing	pages 153, 268

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV	not captured	standing	pages 46, 52, 269
Hypoglycemia	peds	5 mL/kg	IV	not captured	standing	pages 46, 52, 269
Other	adult	25 g	IV	not captured	standing	pages 46, 52, 269
Other	peds	1–2 mL/kg	IV/IO	not captured	standing	pages 207, 234, 269
Other	peds	2–4 mL/kg	IV/IO	not captured	standing	pages 207, 234, 269
Other	peds	5 mL/kg	IV/IO	not captured	standing	pages 207, 234, 269

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperthermia	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 166, 270
Hyperthermia	peds	0.05 mg/kg	IV/IO	not captured	standing	pages 166, 270
Seizure	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 58, 270, 234
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 58, 270, 234
Seizure	peds	0.5 mg/kg	PR	not captured	standing	pages 234, 270

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25 mg/kg	IV/IO	not captured	standing	pages 94, 95, 271
Other	adult	0.25 mg/kg	IV	not captured	standing	page 95
Narrow-complex tachycardia	adult	0.25 mg/kg	IV/IO	not captured	standing	page 271

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	50 mg	IV/IO/IM/PO	not captured	standing	pages 44, 272
Allergic reaction	peds	1 mg/kg	IV/IO/IM/PO	not captured	standing	pages 44, 272
Other	adult	50 mg	PO	not captured	standing	page 44

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	5–20 mcg/kg	IV/IO	not captured	standing	pages 64, 88, 90, 273, 274
Sepsis	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 61

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 44, 276
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 44, 276
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 81, 83, 202, 223, 224, 276
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 81, 83, 202, 223, 224, 276
Hypotension / shock	adult	10 mcg	IV/IO	not captured	standing	pages 61, 64, 90
Other	adult	0.3 mg	IM	not captured	standing	page 44
Other	adult	1 mL	IV/IO	not captured	standing	pages 61, 64, 74, 90, 275
Other	peds	0.1 mL/kg	IV/IO	not captured	standing	pages 223, 224, 276
Other	peds	0.1 mL/kg	ET	not captured	standing	pages 223, 224, 276
Other	peds	0.15 mg	IM	not captured	standing	page 276
Other	peds	0.3 mg	IM	not captured	standing	page 276
Other	peds	0.5 mL	NEB	not captured	standing	page 277
Respiratory distress	adult	0.3–0.5 mg	IM	not captured	standing	pages 48, 276
Respiratory distress	peds	0.01 mg/kg	IM	not captured	standing	pages 48, 276

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.3 mg/kg	IV/IO	not captured	standing	page 19
Procedural sedation	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 94, 95, 96
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	page 19

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1 mcg/kg	IV/IO	not captured	standing	pages 85, 86, 279
Other	adult	0.5 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 279
Other	adult	0.5 mcg/kg	IV/IO	not captured	standing	pages 85, 279
Other	adult	0.5–1 mcg/kg	IV/IO	not captured	standing	page 86
Other	adult	50 mcg	IV/IO/IM/IN	not captured	standing	page 279
Severe pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 279
Severe pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 279
Post-intubation sedation	adult	1 mcg/kg	IV/IO	not captured	standing	pages 19, 279

G–L Glucagon, Haloperidol, Hydralazine, Hydroxocobalamin, Hypertonic Saline, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Levalbuterol, Lidocaine, Lorazepam13

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV/IM	not captured	standing	pages 177, 280
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg (max 1 mg)	IV/IM	not captured	standing	pages 177, 280
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 46, 52, 280
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 46, 52, 280
Other	peds	0.1 mg/kg	not captured	not captured	standing	page 280
Other	peds	1 mg	IM/IN	not captured	standing	pages 207, 234, 280

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10 mg	IM	not captured	standing	pages 41, 281
Agitation	adult	5 mg	IV	not captured	standing	pages 41, 281

Hydralazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV	not captured	standing	pages 106, 278

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 159
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 159

Hypertonic Saline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	250 mL	not captured	not captured	standing	page 140
Other	adult	250 mL	IV	not captured	standing	page 140

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	10 mg/kg	PO	not captured	standing	pages 153, 282
Mild to moderate pain	adult	10 mg/kg	PO	not captured	standing	pages 25, 282
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 25, 282

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Respiratory distress	adult	0.5 mg	NEB	not captured	standing	pages 44, 48, 71, 261
Respiratory distress	peds	0.5 mg	NEB	not captured	standing	pages 44, 48, 71, 261

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.2 mg/kg	IV/IO/IM	not captured	standing	pages 85, 283
ACS / chest pain	adult	0.5 mg/kg	IN	not captured	standing	pages 85, 283
Severe pain	adult	0.2 mg/kg	IV/IO/IM	not captured	standing	pages 25, 283
Severe pain	adult	0.5 mg/kg	IN	not captured	standing	pages 25, 283
Post-intubation sedation	adult	1 mg/kg	IV/IO	not captured	standing	pages 19, 283
Procedural sedation	adult	0.5 mg/kg	IN	not captured	standing	pages 74, 283
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	pages 19, 283

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	15 mg	IV	not captured	standing	pages 25, 284
Severe pain	adult	30 mg	IM	not captured	standing	pages 25, 284

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mg	IV	not captured	standing	pages 106, 285

Levalbuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Respiratory distress	peds	0.31 mg	NEB	not captured	standing	pages 204, 205, 228

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 83, 286
Cardiac arrest	peds	1 mg/kg	IV/IO	not captured	standing	pages 83, 286
Mild to moderate pain	adult	40 mg	IO	not captured	standing	pages 286, 330
Mild to moderate pain	peds	0.5 mg/kg	IO	not captured	standing	pages 286, 330
Narrow-complex tachycardia	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 96, 286
Narrow-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	pages 96, 286

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	IV/IM	not captured	standing	pages 41, 290
Other	adult	0.1 mg/kg	IM	not captured	standing	pages 58, 290
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 58, 290

M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nerve Agent Antidote Kit, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose11

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 g	IV	not captured	standing	pages 48, 291
Other	adult	2 g	IV/IO	not captured	standing	pages 83, 291
Other	adult	2 g	IV	not captured	standing	pages 48, 291
Other	adult	2 g	IV/IO	not captured	standing	pages 83, 291
Other	adult	4 g	IV/IM	not captured	standing	pages 107, 291
Other	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 83, 291
Other	peds	50 mg/kg	IV	not captured	standing	pages 48, 291
Wide-complex tachycardia	adult	2 g	IV/IO	not captured	standing	pages 96, 291
Wide-complex tachycardia	peds	25–50 mg/kg	IV/IO	not captured	standing	pages 96, 291

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	125 mg	IV/IO/IM	not captured	standing	pages 44, 48, 292
Allergic reaction	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 44, 48, 292
Other	adult	125 mg	IV/IO/IM	not captured	standing	pages 44, 48, 292
Other	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 44, 48, 292
Other	peds	2 mg/kg	IV/IM	not captured	standing	page 292

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5 mg	IV	not captured	standing	pages 94, 95, 293

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV/IM/IN	not captured	standing	pages 41, 294, 295
Agitation	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 41, 294, 295
Other	adult	0.05 mg/kg	IV/IO	not captured	standing	pages 19, 294
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 58, 234, 294
Other	adult	0.2 mg/kg	IM/IN	not captured	standing	pages 58, 294
Other	adult	2 mg	IV/IN	not captured	standing	pages 166, 294, 295
Other	adult	5 mg	IM/IN	not captured	standing	pages 41, 58, 294, 295
Other	adult	5 mg	IV/IM	not captured	standing	pages 41, 294
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 58, 234, 294
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 295
Other	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 41, 58, 294, 295
Other	peds	0.2 mg/kg	IV/IN	not captured	standing	pages 166, 294, 295
Other	peds	0.2 mg/kg	IV/IO/IM/IN	not captured	standing	page 295
Procedural sedation	adult	2 mg	IV/IO/IN	not captured	standing	pages 74, 294

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–4 mg	IV/IO	not captured	standing	pages 85, 296
Severe pain	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 25, 296
Severe pain	adult	0.1 mg/kg	IM/SQ	not captured	standing	pages 25, 296
Severe pain	adult	0.1 mg/kg	IV/IO/IM/SQ	not captured	standing	pages 25, 296
Severe pain	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 25, 296
Severe pain	peds	0.1 mg/kg	IM/SQ	not captured	standing	pages 25, 296
Severe pain	peds	0.1 mg/kg	IV/IO/IM/SQ	not captured	standing	pages 25, 296

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IN	not captured	standing	pages 176, 241, 243, 297
Opioid overdose	adult	0.4–2 mg	IM	not captured	standing	pages 176, 241, 243, 297
Opioid overdose	adult	0.4–2 mg	IV/IO	not captured	standing	page 297
Opioid overdose	peds	0.1 mg/kg	IN	not captured	standing	pages 176, 241, 243, 297
Opioid overdose	peds	0.1 mg/kg	IM	not captured	standing	pages 176, 241, 243, 297
Opioid overdose	peds	0.1 mg/kg	IV/IO	not captured	standing	page 297
Opioid overdose	peds	0.1 mg/kg	IM/IN	not captured	standing	pages 241, 243, 297
Other	adult	1 mg (max 2 mg)	IN	not captured	standing	page 176
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 207, 297
Other	peds	0.2 mg/kg	ET	not captured	standing	page 207
Other	peds	2 mg	IM/IN	not captured	standing	pages 207, 241, 243, 297
Other	peds	2 mg	IN	not captured	standing	page 206

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	peds	0.25 mg/kg	IM	not captured	standing	pages 151, 220, 221
Organophosphate poisoning	peds	1 mg	IM	not captured	standing	pages 151, 220, 221
Organophosphate poisoning	peds	2 mg	IM	not captured	standing	pages 151, 220, 221

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 85, 298
ACS / chest pain	adult	1 inch	TOP	not captured	standing	pages 85, 298
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	pages 88, 298
CHF / pulmonary edema	adult	1 inch	TOP	not captured	standing	pages 88, 298

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	2–30 mcg	IV	not captured	standing	pages 61, 64, 88, 90
Other	adult	2–30 mcg	IV	not captured	standing	pages 61, 64, 88, 90, 299
Sepsis	adult	2–30 mcg	IV	not captured	standing	page 61

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	4 mg	IV/IM	not captured	standing	page 177
Nausea / vomiting	adult	4 mg	IV	not captured	standing	pages 56, 300
Nausea / vomiting	adult	8 mg	PO	not captured	standing	pages 56, 300
Nausea / vomiting	peds	0.15 mg/kg	IV	not captured	standing	pages 56, 300
Nausea / vomiting	peds	0.15 mg/kg	IV/IM	not captured	standing	page 300
Nausea / vomiting	peds	4 mg	PO	not captured	standing	pages 56, 300
Other	adult	4 mg	IV/IM/PO	not captured	standing	page 153
Other	adult	4 mg	IV/IM/PO	not captured	standing	page 153

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	pages 52, 301
Hypoglycemia	peds	15 g	PO	not captured	standing	pages 52, 301
Other	adult	15 g	PO	not captured	standing	pages 52, 301
Other	peds	15 g	PO	not captured	standing	pages 52, 301

P–R Pralidoxime, Racemic Epinephrine2

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	pages 151, 220, 221
Nerve agent exposure	peds	15 mg/kg	IM	not captured	standing	pages 151, 220, 221
Other	adult	1200 mg	IM	not captured	standing	pages 220, 221
Other	adult	600 mg	IM	not captured	standing	pages 220, 221
Other	peds	1200 mg	IM	not captured	standing	pages 220, 221
Other	peds	25 mg/kg	IM	not captured	standing	pages 220, 221
Other	peds	300 mg	IM	not captured	standing	pages 220, 221
Other	peds	600 mg	IM	not captured	standing	pages 220, 221
Other	peds	600 mg	IM	not captured	standing	pages 220, 221

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.5 mL	NEB	not captured	standing	page 277

S–Z Sodium Bicarbonate, Thiamine, Tranexamic Acid3

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	pages 50, 81, 133, 177, 302
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 50, 81, 133, 177, 302
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 133, 302
Other	adult	1 mEq/kg	IV	not captured	standing	pages 177, 302
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 133, 302
Other	peds	1 mEq/kg	IV	not captured	standing	pages 177, 302
Tricyclic overdose	adult	1 mEq/kg	IV/IO	not captured	standing	pages 81, 177, 302
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	pages 81, 177, 302

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IM	not captured	standing	pages 46, 52

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV/IO	not captured	standing	pages 147, 303
Other	adult	1 g	IV	not captured	standing	page 303
Other	adult	1 g	IM	not captured	standing	pages 147, 303
Other	adult	500 mg	IN	not captured	standing	page 138
Other	adult	500 mg	not captured	not captured	standing	page 138

Region 4 EMS

Drugs and doses47